Literature DB >> 17919113

HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006.

Thomas d'Aquin Toni1, Bernard Masquelier, Albert Minga, Xavier Anglaret, Christine Danel, Ali Coulibaly, Henri Chenal, François Dabis, Roger Salamon, Hervé J Fleury.   

Abstract

We performed HIV-1 drug resistance genotypic analysis of viral isolates from 100 antiretroviral (ARV)-naive, recently HIV-1-infected (between 2002 and 2006) individuals from Abidjan (Côte d'Ivoire). The overall prevalence of HIV-1 variants with resistance mutations to reverse transcriptase, protease, or fusion inhibitors was 6%. The majority of isolates were CRF02_AG. Compared with a previous study carried out by our group in 2001-2002 in a similar population in Abidjan, our findings confirm the circulation and transmission of HIV-1 carrying key ARV drug resistance mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17919113     DOI: 10.1089/aid.2007.0072

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.

Authors:  Matt A Price; Carole L Wallis; Shabir Lakhi; Etienne Karita; Anatoli Kamali; Omu Anzala; Eduard J Sanders; Linda-Gail Bekker; Rogers Twesigye; Eric Hunter; Pontiano Kaleebu; Kayitesi Kayitenkore; Susan Allen; Eugene Ruzagira; Mary Mwangome; Gaudensia Mutua; Pauli N Amornkul; Gwynn Stevens; Sergei L K Pond; Malinda Schaefer; Mary A Papathanasopoulos; Wendy Stevens; Jill Gilmour
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

2.  Time-scale of minor HIV-1 complex circulating recombinant forms from Central and West Africa.

Authors:  Edson Delatorre; Gonzalo Bello
Journal:  BMC Evol Biol       Date:  2016-11-16       Impact factor: 3.260

3.  Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali.

Authors:  Almoustapha Issiaka Maiga; Djeneba Bocar Fofana; Aichatou Chehy Maiga; Fodie Diallo; Zaina Ait-Arkoub; Fatoumata Daou; Mamadou Cisse; Yaya Dit Sadio Sarro; Aboubacar Alassane Oumar; Aliou Sylla; Christine Katlama; Babafemi Taiwo; Robert Murphy; Anatole Tounkara; Anne-Genevieve Marcelin; Vincent Calvez
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-27       Impact factor: 2.205

4.  Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.

Authors:  Eugène Messou; Marie-Laure Chaix; Delphine Gabillard; Albert Minga; Elena Losina; Vincent Yapo; Martial Kouakou; Christine Danel; Caroline Sloan; Christine Rouzioux; Kenneth A Freedberg; Xavier Anglaret
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04       Impact factor: 3.731

5.  Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.

Authors:  Ouzama Nicholson; Fay DiCandilo; James Kublin; Xiao Sun; Erin Quirk; Michelle Miller; Glenda Gray; Jean Pape; Michael N Robertson; Devan V Mehrotra; Steven Self; Katherine Turner; Jorge Sanchez; Punnee Pitisuttithum; Ann Duerr; Sheri Dubey; Lisa Kierstead; Danilo Casimiro; Scott M Hammer For The Merck V/Hiv Vaccine Trials Network Study Team
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

6.  Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.

Authors:  Arash Memarnejadian; Shahoo Menbari; Seyed Ali Mansouri; Leila Sadeghi; Rouhollah Vahabpour; Mohammad Reza Aghasadeghi; Ehsan Mostafavi; Mohammad Abdi
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 7.  Impact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomes.

Authors:  Allison Langs-Barlow; Elijah Paintsil
Journal:  Viruses       Date:  2014-10-20       Impact factor: 5.048

8.  Spatiotemporal dynamics of the HIV-1 subtype G epidemic in West and Central Africa.

Authors:  Edson Delatorre; Daiana Mir; Gonzalo Bello
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

9.  Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.

Authors:  Henry Dilonga Meriki; Kukwah Anthony Tufon; Damian Nota Anong; Pascal Nji Atanga; Irene Ane Anyangwe; Fidelis Cho-Ngwa; Theresa Nkuo-Akenji
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

10.  Elite and viremic HIV-1 controllers in West Africa.

Authors:  Jean Baptiste N'takpé; Delphine Gabillard; Raoul Moh; Elise Gardiennet; Thomas-d'Aquin Toni; Gérard M Kouame; Anani Badje; Arlette Emieme; Sophie Karcher; Jérome Le Carrou; Hervé Ménan; Christine Danel; Serge P Eholie; Christine Rouzioux; Xavier Anglaret; Olivier Lambotte
Journal:  AIDS       Date:  2022-01-01       Impact factor: 4.177

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.